Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results
Date:3/8/2010

h in total net revenues will significantly accelerate from 7% in 2009 to 15-19% in 2010, driven by broad-based demand for our integrated services platform. China Laboratory Services is expected to achieve revenue growth of 13-16%. Manufacturing Services revenues are expected to grow more than 70% year over year in 2010, benefiting from a large delivery in the first quarter and from generally improving demand. Revenues in U.S.-based Laboratory Services are expected to grow at a mid-single-digit rate. These projections assume very small revenue contributions from the large-scale manufacturing and toxicology businesses in 2010.

"Operating income in 2010 is expected to achieve growth of up to 10 percent compared to 2009, driven by strong revenue growth and increased leverage of SG&A. An expected 2-5 percentage point gross margin decrease, primarily in the second half of 2010, is due to several factors, including an increase in labor and depreciation expenses, expenses from the ramp-up of the toxicology and large-scale GMP manufacturing operations, and pricing pressure. We are working to improve our projected 2010 gross margins. We expect the growth rate in operating income to accelerate in 2011, driven by continued strong revenue growth from China-based laboratory services, meaningful revenues from toxicology and large-scale manufacturing, and improving margins."



                          WUXI PHARMATECH (CAYMAN) INC.
                      UNAUDITED CONSOLIDATED BALANCE SHEETS
            (in thousands of U.S. dollars, except ordinary share,
                             ADS and par value data)

                                                   December 31,   December 31,
                                                       2009     
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing
2. WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
3. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
4. Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
5. WuXi PharmaTech Announces Second-Quarter 2009 Results
6. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
7. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
8. WuXi PharmaTech Receives Award from BASF
9. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
10. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
11. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 On October ... Medicine Showcase in Chicago, leading applied stem cell ... Dr. Wade McKenna presented talks on New Techniques ... Surgical Applications For Stem Cells. , Dr. Riordan ... and the properties of AlphaGEMS that include: wound ...
(Date:10/30/2014)... 2014 James Sherley says he has been ... stem cell technology since his days as a principal investigator ... the late 1990’s. Sherley founded the ASCTC as a ... all the intellectual property developed in Sherley’s research over the ... Institute of Technology (MIT), and more recently as a senior ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the ... fleet of high volume High Pressure Processing (HPP) systems. , ... to PackExpo this year, which is where we first announced ... Williams, CEO at Avure. “Sales of the new Avure machine ... the challenges of market demand for higher throughput. We sold ...
(Date:10/30/2014)... A new report, commissioned by BioCrossroads and conducted by ... at Indiana,s capital market and ... time frames: 1993 to 2002 and 2003 to 2013.  ... investment growth.  The Life Science Innovation Capital in ... innovation dollars as well as an increase in life ...
Breaking Biology Technology:Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 2New report shows Indiana's gains in life sciences innovation capital outpace the nation 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 4New report shows Indiana's gains in life sciences innovation capital outpace the nation 5
... , ... FibraCel disks are a new cell-growth matrix that ... when used in spinners, disposable bottles and bags. New Brunswick,Scientific offers ... FibraStage , a simple,and disposable culture system that outperforms spinners, ...
... , , ... , , ... the,production of a product by means of the mass culture of a ... either be: 1. The cell itself: referred to as biomass production., ...
... , ... , New Brunswick ... virus or,cell mass from anchorage-dependent or suspension cultures.,More productive than traditional roller ... simple to operate, and disposable. Typical,yields of 4.9 x 10 9 ...
Cached Biology Technology:A technique for increasing yields in bioreactors and disposable cell-culture systems 2A technique for increasing yields in bioreactors and disposable cell-culture systems 3A technique for increasing yields in bioreactors and disposable cell-culture systems 4FERMENTATION BASICS 2FERMENTATION BASICS 3FERMENTATION BASICS 4FERMENTATION BASICS 5FERMENTATION BASICS 6FERMENTATION BASICS 7FERMENTATION BASICS 8FERMENTATION BASICS 9FERMENTATION BASICS 10FERMENTATION BASICS 11FERMENTATION BASICS 12FERMENTATION BASICS 13FERMENTATION BASICS 14FERMENTATION BASICS 15FERMENTATION BASICS 16Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 2Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 3Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 4Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 5Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 6Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 7Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 8
(Date:10/29/2014)... from household and industrial products are in the environment ... most of them, scientists have yet to determine whether ... step toward doing that by estimating which substances people ... published in the ACS journal Environmental Science & ... that the risks to human health of any given ...
(Date:10/29/2014)... kind of stem cell, those referred to as ,facultative, ... is apparently nothing that differentiates these cells from the ... they retain the capacity to become stem cells again. ... an organ that hosts cells that stimulate tissue growth, ... case of a transplant. Knowledge of the underlying ...
(Date:10/29/2014)... the international Cancer Genomics of the Kidney consortium ... kidney cancer and exposure to aristolochic acid, an ... in Nature Communications , have important implications ... than 140,000 people every year, and in Central ... part of the International Cancer Genome Consortium (ICGC), ...
Breaking Biology News(10 mins):A mechanism that allows a differentiated cell to reactivate as a stem cell revealed 2Kidney cancer in Central Europe 2
... that some type of protective system goes into action ... deficient. This discovery indicates a hidden safety net that ... immune system such as AIDS. The Mayo Clinic-led study ... is reported in the early online edition of the ...
... for the first time. An international team led by ... Science published an analysis of the marsupial genome in the ... of an important cluster of immune genes known as the ... (Monodelphis domestica), a marsupial found in South America. , ...
... antibacterial coatings on hip and knee implants and biomedical ... surgery and significantly reduce health care costs and improve ... of South Australia have found. , A significant number ... after surgery and in many cases are not amenable ...
Cached Biology News:Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3Marsupial genome reveals insights into mammalian evolution 2Antibacterial coatings cut infection rates 2Antibacterial coatings cut infection rates 3
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Rabbit polyclonal antibody to GluR2...
...
... contains sufficient materials for 1,464 array sample elements. , ... each , Blocker BSA in PBS (10X): 50 ... , BupH Phosphate Buffered Saline: 8 packs , ... West Pico Luminol Enhancer: 2 x 25 ml , ...
Biology Products: